This Blog AMICOR is a communication instrument of a group of friends primarily interested in health promotion, with a focus on cardiovascular diseases prevention.
To contact send a message to
Translate AMICOR contents if you like
Friday, January 13, 2017
From The Lancet: Editor's Choice
Alzheimer’s disease: a first-in-man, phase 1 trial of the safety and immunogenicity of a tau vaccine.